You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
澄清聲明
格隆匯 05-12 15:27

來源:四環醫藥投資者關係

本集團發現路透社於二零二二年五月十二日發表了一篇文章,聲稱華潤集團正與本集團就私有化進行談判,並披露了相關估值及私有化作價等信息。

本集團特此聲明上述新聞內容不屬實,本集團並未與華潤集團或其他任何機構或組織商討上述事項,亦沒有計劃將本集團私有化。

本集團作為香港上市公司,所有消息都會通過港交所公佈,不存在應披露而未披露的信息。

四環醫藥控股集團有限公司

投資者關係部

2022年5月12日

四環醫藥控股集團有限公司(香港股份代號:00460.HK)創立於2001年,2010年於香港聯合交易所主板上市,是一家以創新為引領,堅持創新驅動個,擁有獨立領先的自主研發、生產技術平台,具備豐富的全球化產品管線和成熟卓越銷售體系的國際化醫美及製藥企業。四環醫藥聚焦醫美、腫瘤、代謝、糖尿病、心腦血管、現代中藥及工業大麻等高增長治療領域,一直秉承全速推進四環醫美與生物製藥雙輪驅動戰略的整體戰略目標來打造中國領先的醫美和生物醫藥領軍企業。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account